Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 43

1.

A comparison study of a recombinant tumor necrosis factor receptor:Fc fusion protein (rhTNFR:Fc) and methotrexate in treatment of patients with active rheumatoid arthritis in China.

Hu D, Bao C, Chen S, Gu J, Li Z, Sun L, Han X, Ni L.

Rheumatol Int. 2009 Jan;29(3):297-303. doi: 10.1007/s00296-008-0681-x. Epub 2008 Aug 15.

PMID:
18704426
[PubMed - indexed for MEDLINE]
2.

Infliximab and methotrexate in the treatment of rheumatoid arthritis: a systematic review and meta-analysis of dosage regimens.

Zintzaras E, Dahabreh IJ, Giannouli S, Voulgarelis M, Moutsopoulos HM.

Clin Ther. 2008 Nov;30(11):1939-55. doi: 10.1016/j.clinthera.2008.11.007. Review.

PMID:
19108784
[PubMed - indexed for MEDLINE]
3.

Etanercept: an updated review of its use in rheumatoid arthritis, psoriatic arthritis and juvenile rheumatoid arthritis.

Culy CR, Keating GM.

Drugs. 2002;62(17):2493-537. Review.

PMID:
12421111
[PubMed - indexed for MEDLINE]
4.

Treatment with infliximab plus methotrexate improves anemia in patients with rheumatoid arthritis independent of improvement in other clinical outcome measures-a pooled analysis from three large, multicenter, double-blind, randomized clinical trials.

Doyle MK, Rahman MU, Han C, Han J, Giles J, Bingham CO 3rd, Bathon J.

Semin Arthritis Rheum. 2009 Oct;39(2):123-31. doi: 10.1016/j.semarthrit.2008.08.002. Epub 2008 Sep 27. Review.

PMID:
18823645
[PubMed - indexed for MEDLINE]
5.

Etanercept: a review of its use in rheumatoid arthritis.

Jarvis B, Faulds D.

Drugs. 1999 Jun;57(6):945-66. Review.

PMID:
10400407
[PubMed - indexed for MEDLINE]
6.

The soluble tumor necrosis factor receptor etanercept: a new strategy for the treatment of autoimmune rheumatic disease.

Cole P, Rabasseda X.

Drugs Today (Barc). 2004 Apr;40(4):281-324. Review.

PMID:
15190385
[PubMed - indexed for MEDLINE]
7.

A systematic review and meta-analysis of the efficacy and safety of etanercept for treating rheumatoid arthritis.

Wiens A, Correr CJ, Pontarolo R, Venson R, Quinalha JV, Otuki MF.

Scand J Immunol. 2009 Oct;70(4):337-44. doi: 10.1111/j.1365-3083.2009.02296.x. Review.

PMID:
19751268
[PubMed - indexed for MEDLINE]
8.

Etanercept for the treatment of rheumatoid arthritis.

Blumenauer B, Judd M, Cranney A, Burls A, Coyle D, Hochberg M, Tugwell P, Wells G.

Cochrane Database Syst Rev. 2003;(4):CD004525. Review. Update in: Cochrane Database Syst Rev. 2013;5:CD004525.

PMID:
14584021
[PubMed - indexed for MEDLINE]
9.

Clinical pharmacokinetics of etanercept: a fully humanized soluble recombinant tumor necrosis factor receptor fusion protein.

Zhou H.

J Clin Pharmacol. 2005 May;45(5):490-7. Review.

PMID:
15831771
[PubMed - indexed for MEDLINE]
10.

Golimumab: in the treatment of rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.

Oldfield V, Plosker GL.

BioDrugs. 2009;23(2):125-35. doi: 10.2165/00063030-200923020-00005. Review.

PMID:
19489653
[PubMed - indexed for MEDLINE]
11.

Recombinant human tumor necrosis factor receptor (p75) Fc fusion protein (TNFR:Fc) in rheumatoid arthritis.

Murray KM, Dahl SL.

Ann Pharmacother. 1997 Nov;31(11):1335-8. Review.

PMID:
9391689
[PubMed - indexed for MEDLINE]
12.

Etanercept: therapeutic use in patients with rheumatoid arthritis.

Garrison L, McDonnell ND.

Ann Rheum Dis. 1999 Nov;58 Suppl 1:I65-9. Review.

PMID:
10577976
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

[IL-1Ra (recombinant human IL-1 receptor antagonist) in the treatment of rheumatoid arthritis: the efficacy].

Fiocco U, Vezz├╣ M, Cozzi L, Todesco S.

Reumatismo. 2004 Jan-Mar;56(1 Suppl 1):62-73. Review. Italian.

PMID:
15201942
[PubMed - indexed for MEDLINE]
14.

Examining the efficacy of biologic therapy: are there real differences?

Fleischmann RM.

J Rheumatol Suppl. 2002 Sep;65:27-32. Review.

PMID:
12236619
[PubMed - indexed for MEDLINE]
15.

Anakinra: review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis.

Furst DE.

Clin Ther. 2004 Dec;26(12):1960-75. Review.

PMID:
15823761
[PubMed - indexed for MEDLINE]
16.

Durability and rapidity of response to anakinra in patients with rheumatoid arthritis.

Schiff MH.

Drugs. 2004;64(22):2493-501. Review.

PMID:
15516150
[PubMed - indexed for MEDLINE]
17.

Etanercept: a review of its use in the management of rheumatoid arthritis.

Dhillon S, Lyseng-Williamson KA, Scott LJ.

Drugs. 2007;67(8):1211-41. Review. Erratum in: Drugs. 2007;67(13):1849.

PMID:
17521223
[PubMed - indexed for MEDLINE]
18.

Soluble tumor necrosis factor receptor (p75) fusion protein (ENBREL) as a therapy for rheumatoid arthritis.

Moreland LW.

Rheum Dis Clin North Am. 1998 Aug;24(3):579-91. Review.

PMID:
9710888
[PubMed - indexed for MEDLINE]
19.

"Stepping-up" from methotrexate: a systematic review of randomised placebo controlled trials in patients with rheumatoid arthritis with an incomplete response to methotrexate.

Hochberg MC, Tracy JK, Flores RH.

Ann Rheum Dis. 2001 Nov;60 Suppl 3:iii51-4. Review. No abstract available.

PMID:
11890654
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

[62nd Congress of the American College of Rheumatology, San Diego, 8-12 November 1998].

Cherin P.

Rev Med Interne. 1999 Apr;20(4):311-7. Review. French. No abstract available.

PMID:
10327473
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk